Indian companies race to produce generic Ozempic as patent expires
- Posted on February 20, 2026
- By CNN
- 2 Views
Indian companies race to produce generic Ozempic as patent expires
As the patent for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic versions.
